Replies to post #17919 on Biostax Corp (BTAX)

[goforthebet]

with all clinical trials Cytocom has in the pipeline it would be very strange (after the merger) if the share price of CYTO respec. CBLI would stay that low as it is now. I believe over the next years we should see 20+ a share.